PLANTS

Language selector

Accessibility tools

Navigation path

Status under Reg. (EC) No 1107/2009 (repealing Directive 91/414/EEC )
Legislation 2009/37 ,
Reg. (EU) 2017/1530 ,
Reg. (EU) No 540/2011
   
Date of approval 01/12/2009 Expiration of approval 30/11/2021
RMS

Co-RMS
HR

AT
Risk Assessment EFSA
Category HB Review Report   Specification 2010
  Confirmatory data 2012
Remarks Extension of the approval period: Reg. (EU) 2017/1530

The classification of the tefuryl variant is reported in the specific entry Quilofop-P-tefuryl

The original Co-RMS was UK.
Type Candidate for Substitution (CfS) CfS - criteria toxic for reproduction 1A / 1B
Authorisation at national level
Authorised in In progress for
AT, BE, BG, CY, CZ, DE, EE, EL, ES, FI, FR, HR, HU, IE, IT, LT, LU, LV, MT, NL, PL, PT, RO, SI, SK, UK
EU - Maximum Residue Levels (Reg. (EC) No 396/2005) (MRLs)
Legislation Annexes
  • Quizalofop, incl. quizalfop-P
    MRLs Annex IIIA
Classification Reg. 1272/2008
Acute Tox. 4 - H302 Muta. 2 - H341
Repr. 1B - H360Df STOT RE 2 - H373
Aquatic Acute 1 - H400 Aquatic Chronic 1 - H410
Toxicological information
Reference values Source Remark
ADI  
ARfD  
AOEL  
ADI 0.013 EFSA 08 Tox Info for Quizalofop-P-tefuryl 
ARfD 0.1 EFSA 08 Tox Info for Quizalofop-P-tefuryl 
AOEL 0.01 EFSA 08 Tox Info for Quizalofop-P-tefuryl 
Other
 
Legend
  • RMS:Rapporteur Member State
  • Co-RMS:Co-Rapporteur Member State
  • ADI:Acceptable daily intake
  • ARfD:Acute reference dose
  • AOEL:Acceptable operator exposure level